← Back
Data updated: Mar 10, 2026
MERZ
Neurology
MERZ is a pharmaceutical company focused on Neurology. Key products include INBRIJA.
2010
Since
2
Drugs
-
Trials
0
Approved (2yr)
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
2 drugs Phase 3: 2
Pipeline Strength Pro
Loading...